Marker Therapeutics, Inc. (MRKR) › Total AssetsMarker Therapeutics, Inc. (MRKR) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $116.4K2011: $307.9K2012: $87.4K2013: $77.0K2015: $6.65M2016: $7.92M2017: $5.18M2018: $62.14M2019: $46.36M2020: $45.61M2021: $68.14M2022: $34.42M2023: $17.13M2024: $22.02M2025: $19.07M$19.07M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$19.07M-13.4%2024$22.02M+28.6%2023$17.13M-50.2%2022$34.42M-49.5%2021$68.14M+49.4%2020$45.61M-1.6%2019$46.36M-25.4%2018$62.14M+1099.6%2017$5.18M-34.6%2016$7.92M+19.2%2015$6.65M—2013$77.0K-11.8%2012$87.4K-71.6%2011$307.9K+164.5%2010$116.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share